Marta Schirripa
0000-0001-8316-4411
Publication & Citation Trends
Publications
0 total
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER study
Cited by 0
Semantic Scholar
[CHALLENGE accepted! Exercise in oncology: from "Supportive Care" to "Effective Treatment".]
Cited by 0
Semantic Scholar
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.
Cited by 0
Semantic Scholar
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab.
Cited by 0
Semantic Scholar
880eP Conversion therapy with encorafenib + cetuximab (EC) for chemo-refractory BRAF V600E-mutated oligometastatic colorectal cancer (OM-CRC): A tertiary center experience
Cited by 0
Semantic Scholar
Clinicomics for predicting HER2 expression in metastatic colorectal cancer: a multicenter machine learning analysis on real-world data.
Cited by 1
Semantic Scholar
Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy.
Cited by 1
Semantic Scholar
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC‐D Index
Cited by 5
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(195)
Lung Cancer Treatments and Mutations
(55)
Cancer Treatment and Pharmacology
(55)
Genetic factors in colorectal cancer
(51)
Hepatocellular Carcinoma Treatment and Prognosis
(41)
Affiliations
University of Pisa
University of Southern California
Ospedale Santa Chiara
Biogipuzkoa Health Research Institute
Istituto Oncologico Veneto